Germany's Federal Drug Commissioner to Crack Down on Smoking

Jun.03.2024
Germany's Federal Drug Commissioner to Crack Down on Smoking
Germany's federal drug commissioner, Burkhard Blienert, vows to crack down on smoking advertising to combat tobacco-related deaths and economic losses.

According to Finanz Nachrichten on May 30th, Burkhard Blienert, the Federal Drug Commissioner of Germany, recently stated that efforts to combat smoking issues will continue. Blienert emphasized that advertising is one of the primary factors that contribute to people continuing to smoke, and therefore unrestricted advertising of tobacco and e-cigarettes must be restricted.


He said that despite seeing fewer and fewer young people smoking, Germany still faces significant challenges. It is known that tobacco and nicotine consumption in Germany leads to an annual death toll of as high as 127,000, causing economic losses as high as 100 billion euros.


The commissioner advocates for studying the serious discussions on smoking issues in other countries. He listed some effective policies, such as a total ban on advertising, withdrawing sponsorship from tobacco companies, strengthening smoking cessation support, increasing tobacco taxes, and providing stricter protection for non-smokers, especially children exposed to secondhand smoke.


Blinnett publicly stated his opposition to disposable e-cigarettes, recommending an immediate nationwide ban on these products rather than waiting for potential future regulations in Europe.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Guam DOE: Police to respond to all school-campus incidents involving minors and nicotine products
Guam DOE: Police to respond to all school-campus incidents involving minors and nicotine products
According to the Guam Department of Education (GDOE), police officers will now assist in handling incidents involving minor students who vape or use tobacco products on public school campuses, and cases may be forwarded to the Office of the Attorney General.
Jan.15 by 2FIRSTS.ai
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
New York directs Tax and Finance to build “Vapor Products” registry; products not listed deemed illegal
New York directs Tax and Finance to build “Vapor Products” registry; products not listed deemed illegal
New York Gov. Kathy Hochul says the state will crack down on illegal flavored vapes by creating a registry identifying which vapor products may be legally sold. The governor directed the state Department of Taxation and Finance to establish a “Vapor Products” registry, with products not on the list treated as illegal.
Jan.20 by 2FIRSTS.ai
Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Vladislav Grib, deputy secretary of the Public Chamber of the Russian Federation, said a “generational ban” on cigarette sales—restricting sales based on year of birth—would not resolve smoking and would instead lead to human rights violations. He argued older cohorts would buy and share, and the approach would split citizens into two categories.
Jan.08 by 2FIRSTS.ai
Malaysia’s MOH aims to implement a vape ban in 2026, starting with open pod systems
Malaysia’s MOH aims to implement a vape ban in 2026, starting with open pod systems
Bernama (Malaysia’s national news agency) reported that Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Ministry of Health aims to implement a vape ban this year, beginning with open pod systems, and will not compromise on enforcing the Control of Smoking Products for Public Health Act 2024 (Act 852).
Jan.06 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24